Acinetobacter baumannii Sequence Types Harboring Genes Encoding Aminoglycoside Modifying Enzymes and 16SrRNA Methylase; a Multicenter Study from Pakistan

References

• McGann P, Courvalin P, Snesrud E, et al. Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure. MBio. 2014;5(2):e00915. doi:10.1128/mBio.00915-14
   PubMed Web of Science ®Google Scholar
• Khurshid M, Rasool MH, Ashfaq UA, Aslam B, Waseem M. Emergence of ISAba1 harboring carbapenem-resistant Acinetobacter baumannii isolates in Pakistan. Future Microbiol. 2017;12:1261–1269. doi:10.2217/fmb-2017-008028980827
   PubMed Web of Science ®Google Scholar
• Khurshid M, Rasool MH, Ashfaq UA, et al. Dissemination of blaOXA-23 harboring Carbapenem-resistant Acinetobacter baumannii clones in Pakistan. J Glob Antimicrob Resist. 2020;21:357–362. doi:10.1016/j.jgar.2020.01.00132006748
   PubMed Web of Science ®Google Scholar
• Khurshid M, Rasool MH, Siddique MH, et al. Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii. J Infect Dev Ctries. 2019;13(10):899–905. doi:10.3855/jidc.1141032084020
   PubMed Web of Science ®Google Scholar
• Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev. 2012;25(3):450–470. doi:10.1128/CMR.05041-1122763634
   PubMed Web of Science ®Google Scholar
• Nørgaard SM, Jensen CS, Aalestrup J, Vandenbroucke-Grauls C, de Boer MGJ, Pedersen AB. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review. Antimicrob Resist Infect Control. 2019;8:170. doi:10.1186/s13756-019-0624-131709047
   PubMed Web of Science ®Google Scholar
• Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: an overview. Cold Spring Harb Perspect Med. 2016;6:6. doi:10.1101/cshperspect.a027029
   Web of Science ®Google Scholar
• Sohail M, Rashid A, Aslam B, et al. Antimicrobial susceptibility of Acinetobacter clinical isolates and emerging antibiogram trends for nosocomial infection management. Rev Soc Bras Med Trop. 2016;49(3):300–304. doi:10.1590/0037-8682-0111-201627384826
   PubMed Web of Science ®Google Scholar
• Costello SE, Deshpande LM, Davis AP, Mendes RE, Castanheira M. Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates. J Glob Antimicrob Resist. 2019;16:278–285. doi:10.1016/j.jgar.2018.10.02030389638
   PubMed Web of Science ®Google Scholar
• Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658. doi:10.2147/IDR.S17386730349322
   PubMed Web of Science ®Google Scholar
• Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev. 2003;16(3):430–450. doi:10.1128/CMR.16.3.430-450.200312857776
   PubMed Web of Science ®Google Scholar
• Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol. 2004;53(Pt 12):1233–1240. doi:10.1099/jmm.0.45716-015585503
   PubMed Web of Science ®Google Scholar
• Taitt CR, Leski TA, Stockelman MG, et al. Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother. 2014;58(2):767–781. doi:10.1128/AAC.01897-1324247131
   PubMed Web of Science ®Google Scholar
• Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;6:25–64. doi:10.4137/PMC.S1445925232278
   PubMedGoogle Scholar
• Ayad A, Drissi M, de Curraize C, et al. Occurrence of arma and rmtb aminoglycoside resistance 16S rRNA methylases in extended-spectrum β-Lactamases producing escherichia coli in algerian hospitals. Front Microbiol. 2016;7:1409. doi:10.3389/fmicb.2016.0140927672380
   PubMed Web of Science ®Google Scholar
• Sader HS, Farrell DJ, Flamm RK, Jones RN. Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012). Antimicrob Agents Chemother. 2014;58(4):2274–2280. doi:10.1128/AAC.02684-1324492361
   PubMed Web of Science ®Google Scholar
• Al-Atrouni A, Hamze M, Jisr T, et al. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int J Infect Dis. 2016;52:29–36. doi:10.1016/j.ijid.2016.09.01727663910
   PubMed Web of Science ®Google Scholar
• Aghazadeh M, Rezaee MA, Nahaei MR, et al. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among Acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist. 2013;19(4):282–288. doi:10.1089/mdr.2012.022323577624
   PubMed Web of Science ®Google Scholar
• Sheikhalizadeh V, Hasani A, Ahangarzadeh Rezaee M, et al. Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii. J Infect Chemother. 2017;23(2):74–79. doi:10.1016/j.jiac.2016.09.01227889248
   PubMed Web of Science ®Google Scholar
• Davies J, Wright GD. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 1997;5(6):234–240. doi:10.1016/S0966-842X(97)01033-09211644
   PubMed Web of Science ®Google Scholar
• Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat. 2010;13(6):151–171. doi:10.1016/j.drup.2010.08.00320833577
   PubMed Web of Science ®Google Scholar
• Xiao-Min X, You-Fen F, Wei-Yun F, Zu-Huang M, Xing-Bei W. Antibiotic resistance determinants of a group of multidrug-resistant Acinetobacter baumannii in China. J Antibiot. 2014;67(6):439–444. doi:10.1038/ja.2014.1824619228
   PubMed Web of Science ®Google Scholar
• Gholami M, Haghshenas M, Moshiri M, et al. Frequency of 16S rRNA methylase and aminoglycoside-modifying enzyme genes among clinical isolates of Acinetobacter baumannii in Iran. Iran J Pathol. 2017;12(4):329–338. doi:10.30699/ijp.2017.2798929563928
   PubMedGoogle Scholar
• Chen Y, Yang Y, Liu L, et al. High prevalence and clonal dissemination of OXA-72-producing Acinetobacter baumannii in a Chinese hospital: a cross sectional study. BMC Infect Dis. 2018;18(1):491. doi:10.1186/s12879-018-3359-330268099
   PubMed Web of Science ®Google Scholar
• Li Y, Guo Q, Wang P, et al. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 beta-lactamase at a teaching hospital in Shanghai, China. J Microbiol Immunol Infect. 2015;48(1):101–108. doi:10.1016/j.jmii.2014.04.00524863499
   PubMedGoogle Scholar
• Salto IP, Torres Tejerizo G, Wibberg D, Puhler A, Schluter A, Pistorio M. Comparative genomic analysis of Acinetobacter spp. plasmids originating from clinical settings and environmental habitats. Sci Rep. 2018;8(1):7783. doi:10.1038/s41598-018-26180-329773850
   PubMed Web of Science ®Google Scholar
• Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol. 2007;45(2):453–460. doi:10.1128/JCM.01971-0617108068
   PubMed Web of Science ®Google Scholar
• Saffari F, Monsen T, Karmostaji A, Azimabad FB, Widerström M. Significant spread of extensively drug-resistant Acinetobacter baumannii genotypes of clonal complex 92 among intensive care unit patients in a university hospital in southern Iran. J Med Microbiol. 2017;66(11):1656–1662. doi:10.1099/jmm.0.00061929058650
   PubMed Web of Science ®Google Scholar
• Saharman YR, Karuniawati A, Sedono R, et al. Endemic carbapenem-nonsusceptible Acinetobacter baumannii-calcoaceticus complex in intensive care units of the national referral hospital in Jakarta, Indonesia. Antimicrob Resist Infect Control. 2018;7:5. doi:10.1186/s13756-017-0296-729344351
   PubMed Web of Science ®Google Scholar
• Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother. 2010;65(10):2253–2254. doi:10.1093/jac/dkq27320650909
   PubMed Web of Science ®Google Scholar
• Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother. 2012;56(4):2184–2186. doi:10.1128/AAC.05961-1122252797
   PubMed Web of Science ®Google Scholar
• Taj Z, Rasool MH, Almatroudi A, Saqalein M, Khurshid M. Extensively drug-resistant Acinetobacter baumannii belonging to international clone II from a pet cat with urinary tract infection; the first report from Pakistan. Pol J Microbiol. 2020;69(2):231–234. doi:10.33073/pjm-2020-017
   Web of Science ®Google Scholar